Focus on the improvement of quality innovation, sword refers to the development of 100 billion -level industries

In the field of large health, the biomedical industry has always been called "never decline in the sun." As a city of innovation, Zibo High -tech Zone is always creating a miracle. Biomedical innovative industrial clusters, from scratch, from nothing, from excellent, from excellent to special, agglomerate to promote industrial transformation, focus on traditional industries to rejuvenate, lead the development of industrial gathering groups, Zibo High -tech Zone uses transformation to answer the development of development development. Asked, the new test was welcome with the attitude of the examiner. The industrial cluster gathered and rearracted, and the 100 billion -level biopharmaceutical industry was glory.

Stable and efficient industries are distinctive

As one of the "3+2" leading industries in Zibo High -tech Zone, the biomedical industry has continued to enhance the industrial strength after more than 70 years of development. As a well -known biomedical characteristic industry base in the country, a large number of talents and projects have been brought together. The carrier and support platform forms an industrial pattern of medical pharmaceutical and medical devices, and the booming industrial forms of new industries and new formats. In recent years, based on the advantages of biomedical characteristic industrial bases, with the introduction of iconic projects, the cultivation of leading enterprises, and the gathering of innovative resource elements as the breakthrough, Zibo High -tech Zone actively promotes the industrial chain, innovation chain, talent chain, service chain, capital chain, and capital chain,, capital chain, capital chain, and capital chain,, capital chain, capital chain, capital chain, capital chain, capital chain, capital chain, capital chain, capital chain, and capital chain,, capital chain, capital chain, capital chain, capital chain, and capital chain,, capital chain, capital chain, capital chain, capital chain, capital chain, capital chain, capital chain, capital chain, and capital chain, and capital chains, and capital chains, capital chains, capital chains, and capital chains, and capital chains, and capital chains. The collaborative linkage of the value chain, build a high -end biomedical industry ecosystem, and create a domestic first -class domestic high -end biomedical industry with outstanding innovation capabilities, strong industrial competitiveness, and beautiful ecological environment.

The quality of Juli Industry has improved, and Zibo High -tech Zone vigorously develops a number of industry leaders in the biomedical industry cluster to occupy the commanding heights with advanced technology. Earlier this year, Xinhua Pharmaceutical relying on its leading technology level and relying on its own high -purity EPA fish oil raw materials, high -purity fish oil health products, worked hard on purity and composition, and developed a series of products, including pure pure fish oil market, including pure pure products, including pure pure EPA series products (70, 80, 90 and pharmaceutical EPA98), Gaocun DHA series products (70, 85, 90 and pharmaceutical DHA95) and hybrid series products (total Omega-3 greater than 90, medicine grade), medicine grade) The global industry is leading.

In accordance with the industrial organization concept of "keeping close to the frontier, building ecology, aggregation along the chain, and clustering", Zibo High -tech Zone is striving to build a 100 billion -level biomedical industry. After years of development, the current Zibo High -tech Zone has gathered a number of advantageous backbone enterprises, forming a complete industrial chain from science and technology research and development to project industrialization. Functional food, pharmaceutical packaging materials and CRO services, involving 8 small categories of 9 small categories in the 9 small categories of the "Classification of the National Economic Industry" (GB/T4754-2017), 8 small categories of medical instruments and equipment and equipment manufacturing industry 7 of the classification, more than 130 biomedical companies, including 25 companies above designated size, creating two characteristic industrial clusters, pharmaceutical and medical equipment. In the field of medical equipment and pharmaceutical equipment, medical images, sterilization equipment, medical consumables, preparation equipment, blood equipment and other aspects have strong international competitiveness.

Research and development innovative technology survival strength

The existing industry is a "gold mine". The key to opening the "Gold Mine" is in new technologies, new formats, and new models.

In order to enhance the innovation capabilities of the Zibo High -tech Zone, Zibo High -tech Zone gathered superior resources, invested 1 billion yuan, and cooperated with Shandong University to build the Zibo Biomedical Research Institute of Shandong University, and used this to create a biomedical innovation platform -biology Pharmaceutical Innovation Park (national science and technology enterprise incubator), gathered in Shandong more than 20 pharmaceutical CRO companies, with 6 national enterprise technology centers such as Xinhua Pharmaceutical and Xinhua Medical, liver disease targeting drug engineering technology research centers, safe infusion 37 provincial -level enterprises such as the System Engineering Technology Research Center have formed a characteristic industrial innovation system that integrates research and development, incubation, acceleration, industrialization, demonstration and gathering. In recent years, the district has undertaken 27 national plans and more than 40 provincial plans, and a total of 3,394 patents have been authorized, of which 638 invention patents are invention.

In only 5 years, Shandong Zizheng Pharmaceutical Technology Co., Ltd. "graduated" from the Zibo High -tech Zone Biomedical Industrial Park, and quickly became the focus of the industry. It is the fastest growing CRO technology service company in the domestic drug preparation field. "The rise of Zheng Medicine's innovation is not isolated." Xu Dong, dean of the Zibo Biomedical Research Institute of Shandong University, said that Zheng Medicine can grow from Zibo High -tech Zone. Both and basic advantages ranks first in the province. Relying on the platform, the Zibo High -tech Zone Biomedical Industrial Park introduces outstanding innovation resources at home and abroad, cooperates with local enterprises to form a complete innovation system, build medical science and technology innovation and development and development The micro -ecology.

With the sails, the behavior of the behavior can be Hengyuan. The development of the industry is inseparable from the support of the "leader". The leading enterprise is the "target heart" of industrial transformation and upgrading and building the core competitiveness of industrial clusters. Zibo High -tech Zone accurately hit this "target heart". Jincheng Kerry, an internationally leading cephalosporin pharmaceutical intermediate production enterprise, product cephalosporin side chain -side -chain acid activated global market share reached 95%; Beliga Pharmaceutical, the best OTC drug (ibuprofen) supply in the world Commercial, all products are sold to the US market; Rongchang Pharmaceuticals, independently developed national Chinese medicine three types of new medicines, stinging in the domestic market, filling the domestic market gaps; Asia University Pharmaceuticals, the global exclusive product, the Global Products, is authorized by the National Invention Patent. It is the crystallization of modern biotechnology and traditional Chinese medicine theory. In the field of medical device, Xinhua Medical Devices, with the world's number one water bathing device equipment, the national technology first large -capacity sterile floppy bag and sealing all -in -one; The top three in the world; Ante Medical, the technical level of the TPE infusion device is the world's leading, selling the first nationwide ... When highlighting, it is gathered by "remittance". Zibo High -tech Zone continues to embed new elements, create new combinations, embrace new variables, drives the industry upgrade with clusters, drives the supply and demand connection with the platform, and continuously pushes the two articles of "excellent" and "expand" with capital -driven value. Another industry leader project scrambled to settle down, building the four beams and eight pillars of the biomedical industry, which not only brought the current quality and speed of development to the Zibo High -tech Zone, but also reserved future development momentum.

Juli high -end leading new track

The pharmaceutical industry can be called a high -quality gold track, and CRO/CMO/CDMO is the diamond track in this gold track. At present, the global pharmaceutical market competition is increasingly fierce, and the division of industrial chain in the pharmaceutical industry has become increasingly perfect. CMO (contract custom production institution) and CDMO (contract custom R & D and production institutions) have become two major forms of commissioned R & D and production forms. "As pharmaceutical companies continue to strengthen the requirements of cost control and efficiency improvement, traditional CMO companies have relying on the production processes and technical support provided by pharmaceutical companies to carry out single OEM production services." Xu Dong said that in recent years, in recent years, in recent years With the continuous development of the biomedical industry, biomedical outsourcing companies such as CRO, CMO, and CDMO have also risen. Enterprises in the park have established core competitiveness through special technology platforms or services to achieve breakthroughs in various segments.

It is understood that around China (Zibo) International Pharmaceutical CRO & CMO & CDMO base, Zibo High -tech Zone focuses on building biomedical incubators, professional public technical service platforms (Shan Dabo Biomedical Research Institute), CRO technology service platform, and biomedical industry acceleration platform. R & D and incubation cultivation, the growth of primary pharmaceutical companies, the research and development services of pharmaceutical companies in the region, and the research and development and production of leading pharmaceutical companies in the region to form an innovative research and development think tank for regional biomedical industries and the core driver of industrial development. Relying on the innovative research and development of the Zibo Biomedical Research Institute of Shandong University in the early days, and the advantages of Shandong Xinhua Pharmaceutical CDMO foundry, focusing on undertaking industrialized projects such as chemical drug preparations, traditional Chinese medicine preparations, and high -end preparations introduced by the biomedical innovation center. At the same time, it plans to organize high -end summits to introduce international high -end pharmaceutical companies and R & D teams such as Roche and Better to attract more CRO/CMO/CDMO companies and scientific research institutions to build international high -end pharmaceutical bases.

At the time of "birth", this is a new era of sprints to the higher energy -level biomedical industry cluster in Zibo High -tech Zone; "Sheng" is immersed. There is a happy and happy land that allows biopharmaceutical companies to take root and flowering. Zibo High -tech The district has continuously introduced a number of policies and measures to promote the development of the biomedical industry to help the high -quality development of the biomedical industry; the "birth" is endless. With the innovative industry cluster of biomedical and biomedical engineering in Zibo High -tech Zone Industrial cluster pilot (cultivation), Zibo High -tech Zone ushered in a new era of accelerating the biomedical industry. At that time, it had arrived, and its potential was successful.

In 2022, the Zibo High -tech Zone will resolutely implement the seven major actions of "quality improvement in the front", strictly implement the "five first -class" work requirements, highlight the leadership of the quality party building, and achieve the improvement of the quality of the main responsibility. The "chain length system" attracts new formats; focusing on new species and new scenes, and accelerating the construction of the new economy gathering parks. With the improvement of the quality of the new race and new as the quality of the industry, we work hard to achieve the goal of achieving the "100 billion -level biomedical industry".

- END -